Completed NA INTERVENTIONAL 2-arm NCT02924480

Intravenous Lidocaine for Cystectomy Procedures (Lidocaine)

Intravenous Lidocaine in the Perioperative Setting and the Effects on Postoperative Pain and Bowel Function Following Cystectomy: A Pilot Study

Sponsor: CAMC Health System

Conditions Invasive Bladder Cancer

Interventions Cystectomy Lidocaine Saline

Updated 8 times since 2017 Last updated: Mar 7, 2022 Started: Oct 12, 2016 Primary completion: Jun 17, 2020 Completion: Jun 17, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02924480, this NA trial focuses on Invasive Bladder Cancer and remains completed. Sponsored by CAMC Health System, it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Apr 2022 [monthly]

Unknown Status NA
Sep 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Sep 2019 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CAMC Health System

Data source: CAMC Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States